Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate 35 mg Weekly in Men with Osteoporosis
NCT00619957Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Jun 2002
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of risedronate in osteoporosis, sponsored by Warner Chilcott. Started Jun 2002; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00619957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619957.